Works by Yuerong Shuang

Results: 9
    1

    Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial.

    Published in:
    2021
    By:
    • Song, Yuqin;
    • Zhou, Hui;
    • Zhang, Huilai;
    • Liu, Wei;
    • Shuang, Yuerong;
    • Zhou, Keshu;
    • Lv, Fangfang;
    • Xu, Hao;
    • Zhou, Jianfeng;
    • Li, Wei;
    • Wang, Huaqing;
    • Zhang, Hongyu;
    • Huang, Haiwen;
    • Zhang, Qingyuan;
    • Xu, Wei;
    • Ge, Zheng;
    • Xiang, Ying;
    • Wang, Shuye;
    • Gao, Da;
    • Yang, Shun'e
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9

    A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01697-z
    By:
    • Hong, Huangming;
    • Chen, Zegeng;
    • Zhang, Mingzhi;
    • Peng, Zhigang;
    • Shen, Jianzhen;
    • Shuang, Yuerong;
    • Zhou, Hui;
    • Guo, Hongqiang;
    • Huang, He;
    • Li, Fei;
    • Qian, Zhengzi;
    • Liu, Lihong;
    • Wang, Liang;
    • Yang, Wei;
    • Zhang, Liling;
    • He, Pengcheng;
    • Qian, Shen;
    • Li, Fugen;
    • Li, Meng;
    • Lin, Tongyu
    Publication type:
    Article